[EN] HIGH AFFINITY INHIBITORS OF HEPATITIS C VIRUS NS3/4A PROTEASE<br/>[FR] INHIBITEURS À HAUTE AFFINITÉ DE PROTÉASE NS3/4A DU VIRUS DE L'HÉPATITE C
申请人:UNIV JOHNS HOPKINS
公开号:WO2009120783A1
公开(公告)日:2009-10-01
Compositions and uses thereof that inhibit HCV life cycle by inhibiting action of the HCV NS3/4A protease. An embodiment of the invention comprises a compound designated RS-2-19.
Potent low molecular weight, highly selective, competitive non-peptidic serine protease inhibitors and their use in treating serine protease-associated diseases are disclosed.
Potent low molecular weight, highly selective, competitive non-peptidic serine protease inhibitors and their use in treating serine protease-associated diseases are disclosed.